Cardioneuroablation for the Treatment of Hypervagotonic Sinus Node Dysfunction

Arshneel Kochar; Tyler Taigen; Jeffery Courson; Kenneth Mayuga; Shady Nakhla; Oussama Wazni; Pasquale Santangeli

doi:10.1016/j.jaccas.2023.102185

Cardioneuroablation for the Treatment of Hypervagotonic Sinus Node Dysfunction

JACC Case Rep. 2024 Jan 9;29(4):102185. doi: 10.1016/j.jaccas.2023.102185. eCollection 2024 Feb 21.

Authors

Arshneel Kochar¹, Tyler Taigen¹, Jeffery Courson¹, Kenneth Mayuga¹, Shady Nakhla¹, Oussama Wazni¹, Pasquale Santangeli¹

Affiliation

¹ Department of Pacing and Electrophysiology, Cleveland Clinic, Cleveland, Ohio, USA.

Abstract

Hypervagotonic sinus node dysfunction (SND) is a form of SND with sinus bradycardia caused by enhanced vagal tone. Indirect proof of hypervagotonia as the mechanism can be inferred from resolution of bradycardia following atropine infusion. In symptomatic patients, pacemaker implantation is recommended. We describe cardioneuroablation as a treatment for hypervagotonic SND.

Keywords: cardioneuroablation; hypervagotonia; sinus node dysfunction.

Publication types

Case Reports